NeoGenomics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| NEO | PSNL | BLLN | MYGN | NTRA | CSTL | |
|---|---|---|---|---|---|---|
| Market cap | 2.22B | 1.69B | 5.37B | 575.81M | 56.36B | 1.09B |
| P/E (TTM) | — | — | 180.8 | — | — | — |
| Forward P/E | 54.5 | -16.3 | 76.7 | -10.2 | -2,198.8 | -38.2 |
| Price/book | 2.8 | 6.2 | 9.9 | 1.9 | 30.8 | 2.3 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +64.90% | +119.76% | +4.54% | −4.90% | +97.01% | +6.56% |
| Today | +1.90% | +0.25% | +3.11% | −0.33% | +0.62% | +1.74% |
The closest companies by business and industry (Diagnostics & Research). Prices may be delayed up to 15 min.
Latest news
All NEO news ›Colorescience Appoints John Reed As CEO And Names Mary Fisher Vice Chair Of The Board
Colorescience, a premium skincare and mineral sun protection company, has appointed John Reed as Chief Executive Officer, effective November 1, 2026. Reed succeeds Mary Fisher, who has led the company since 2013 and will transition to Vice…
MacroGenics Announces Appointments of Emil Kuriakose, M.D., and Michael Vasconcelles, M.D., to Board of Directors
MacroGenics appointed Dr. Emil Kuriakose and Dr. Michael Vasconcelles as independent directors, effective October 30, 2026. Plus members following MGNX got this by push and email at 16:05:00 ET - 0.7s after publication. MacroGenics…
Neogen Chemicals confirms no deviation in QIP fund utilization
Neogen Chemicals Limited's Monitoring Agency Report for Q3 2026 confirms no deviation in QIP fund utilization, as per CRISIL Ratings. Report reviewed by Audit Committee. Neogen Chemicals confirms no deviation in QIP fund utilization Neogen…
NeoSoul DNA Metrics vs Traditional Crypto Indicators
For the comparison to be meaningful, NeoSoul would need to publish a metrics suite with clear definitions, data sources, update frequency, and historical performance. Until that happens, “NeoSoul DNA metrics” is a placeholder term, not a…
NeoGenomics Expands Indica Labs Partnership to Scale AI-Powered Digital Pathology
NeoGenomics, Inc. (NASDAQ: NEO), a provider of oncology diagnostic solutions that enable precision medicine across the cancer care continuum, has expanded its partnership with Indica Labs, a global ... FORT MYERS, Fla.--(BUSINESS…
NeoGenomics raises 2026 guidance to $807M-$809M while planning CEO transition in January 2027
NeoGenomics Q3 2026: revenue rose 11%, NGS surged, and guidance increased. Earnings Call Insights: NeoGenomics (NEO) Q3 2026 - "Clinical revenue grew 13% year-over-year. NGS revenue grew a strong 29%, and our adjusted gross margins…
NeoGenomics Reports Third Quarter 2026 Results
Total revenue increased 11% YoY to $209 million Clinical services revenue grew 13%, with NGS revenue growth of 29% Company raises full-year 2026 revenue and adjusted EBITDA guidance FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics, Inc.…
NeoGenomics, Inc. 2026 Q3 - Results - Earnings Call Presentation
2026-10-30. The following slide deck was published by NeoGenomics, Inc. The following slide deck was published by NeoGenomics, Inc. in conjunction with their 2026 Q3 earnings call. Q3: 2026-10-28 Earnings Summary
Genmab Publishes 2025 Annual Report
A history of accomplishments rooted in science Genmab Hosts Plenary and Life Science Fair on AI’s Role in the Future of Healthcare and Labs A live and archived webcast of the call and relevant slides will be available at…
NeoGenomics (NEO) Q3 2026 Earnings Call Transcript
Wed, Oct. 28, 2026 Operator: Good afternoon, and welcome to the NeoGenomics Third Quarter 2026 Financial Results Conference Call. Please be advised that today's conference is being recorded. I will now turn the call over to Andrew…
More from 1 other outlet
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com9
- seekingalpha.com4
- tradingview.com3
- biospace.com2
- genomeweb.com2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 43 articles, not a forecast.